Abby Abraham


New Survey Measures the Pulse of RBM & ICH-E6 (R2) Adoption in the Clinical Trials Industry

May 23, 2019

Abby Abraham, Vice President, Data Analytics, and RBM for OmniComm Systems, writes about a new survey that highlights gaps in the conversation surrounding the industry’s adoption and implementation of risk-based approaches to monitoring.